Indegene Ltd (NSE:INDGN)
₹ 577.35 -9 (-1.53%) Market Cap: 139.03 Bil Enterprise Value: 125.66 Bil PE Ratio: 34.78 PB Ratio: 4.42 GF Score: 51/100

Q2 2026 Indegene Ltd Earnings Call Transcript

Oct 31, 2025 / 03:00AM GMT
Release Date Price: ₹539.4 (-2.29%)

Key Points

Positve
  • Indegene Ltd (NSE:INDGN) reported a 17.1% year-on-year revenue growth in Q2 FY26, reaching INR8,042 million.
  • The company successfully converted two more customers into paying clients for its Tectonic platform, increasing its customer base.
  • Indegene Ltd (NSE:INDGN) has made strategic acquisitions, including BioPharm and WARN & CO, to enhance its capabilities and market reach.
  • The company is seeing increased interest in its GenAI-based capabilities, particularly in digital content and medical writing applications.
  • Indegene Ltd (NSE:INDGN) hosted a successful in-person Indegene Digital Summit, gaining valuable insights and reinforcing its AI-focused strategy.
Negative
  • The EBITDA margin for Q2 FY26 decreased by 2% sequentially, primarily due to annual wage hikes and increased marketing expenses.
  • The company anticipates a 1.5% margin compression in the near term due to investments in growth initiatives.
  • Indegene Ltd (NSE:INDGN) experienced a degrowth in its Brand Activation segment by 15.8% in Q2 FY26.
  • The largest customer of Indegene Ltd (NSE:INDGN) showed a revenue decline due to a change in the onsite-offshore mix.
  • The company faces challenges in closing deals in its Brand Activation segment, impacting its growth trajectory.
Operator

Ladies and gentlemen, good day, and welcome to Indegene Limited Q2 FY26 earnings conference call.(Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Abhishek Agarwal from Indegene. Thank you, and over to you, Mr. Agarwal.

Abhishek Agarwal
Indegene Ltd - Head, Investor Relations

Thank you, moderator. A very good morning to all of you and thank you for joining us today for Indegene's earnings conference call for the second quarter and half year ended financial year 2026. Today, we have with us Mr. Manish Gupta, Indegene's Chairman and CEO; and Mr. Suhas Prabhu, CFO, to share the highlights of the business and financials of the quarter.

I hope you have gone through our results release and the quarterly investor presentation, which have been uploaded on our website as well as the stock exchange website. The transcript of this call will be available in a week's time on the company's website. Please note that today's discussion will be forward-looking in nature and must be viewed in relation to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot